Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center.

Maximilian N KinzlerJan JerochChristina KlasenVera HimmelsbachChristine KochFabian Finkelmeier Jörg Trojan Stefan ZeuzemUrsula PessionHenning ReisMelanie C DemesPeter J WildDirk Walter

Published in: Journal of cancer research and clinical oncology (2023)

Patients with IDH1 mutated iCCA seem to have a favorable tumor biology including a longer PFS for palliative chemotherapy regimens compared to IDH1 wild type.

Keyphrases

wild type
palliative care
locally advanced
low grade
advanced cancer